GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2013

Sartorius and BD Sign Microbiological Diagnostics Deal

  • Sartorius Stedim Biotech (SSB) and BD Diagnostics agreed to collaborate on the development, manufacture, and marketing of various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech, and research laboratories.

    “BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD’s expertise combined with Sartorius Stedim Biotech’s know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring,” says Dominique Baly, member of the group executive committee at Sartorius.

    According to Baly, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products. In addition, the companies are exploring options of extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics,” he added.

    “The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech, and research customers with these unique product offerings,” added Bob Ferguson, vp and general manager, BD Diagnostics, diagnostic systems, industrial microbiology. “By combining Sartorius Stedim Biotech’s bioprocessing and filtration expertise with BD’s microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing.”



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?